We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1301
Ascendis Pharma A/S
ASND
$16.8B
$381K 0.01%
4,094
+1,549
+61% +$146K
RWJ icon
1302
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.1B
$381K 0.01%
+11,220
New +$422K
WK icon
1303
Workiva
WK
$3.54B
$381K 0.01%
5,784
+4,679
+423% +$389K
KRTX
1304
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$381K 0.01%
3,009
+2,212
+278% +$254K
BCRX icon
1305
BioCryst Pharmaceuticals
BCRX
$2.4B
$380K 0.01%
35,861
+19,681
+122% +$203K
GBCI icon
1306
Glacier Bancorp
GBCI
$6.35B
$380K 0.01%
8,022
+5,613
+233% +$264K
PB icon
1307
Prosperity Bancshares
PB
$8.89B
$380K 0.01%
5,568
-12,297
-69% -$845K
ONEY icon
1308
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$677M
$378K 0.01%
4,242
+69
+2% +$6.72K
ACAD icon
1309
Acadia Pharmaceuticals
ACAD
$5.03B
$377K 0.01%
26,752
+24,231
+961% +$452K
ALC icon
1310
Alcon
ALC
$35B
$377K 0.01%
5,394
+2,492
+86% +$182K
ALKS icon
1311
Alkermes
ALKS
$8.25B
$377K 0.01%
12,646
+11,347
+874% +$326K
FNDF icon
1312
Schwab Fundamental International Large Company Index ETF
FNDF
$25.7B
$377K 0.01%
13,308
+13,249
+22,456% +$406K
PRKS icon
1313
United Parks & Resorts
PRKS
$2.12B
$377K 0.01%
8,533
+7,304
+594% +$424K
HQY icon
1314
HealthEquity
HQY
$8.75B
$376K 0.01%
6,133
+3,135
+105% +$201K
RFV icon
1315
Invesco S&P MidCap 400 Pure Value ETF
RFV
$337M
$376K 0.01%
4,520
-3,664
-45% -$331K
TCMD icon
1316
Tactile Systems Technology
TCMD
$665M
$376K 0.01%
51,464
+47,983
+1,378% +$608K
LKFN icon
1317
Lakeland Financial Corp
LKFN
$1.53B
$375K 0.01%
5,640
+4,671
+482% +$333K
VRN
1318
DELISTED
Veren
VRN
$374K 0.01%
52,692
-2,703
-5% -$21.2K
GLBE icon
1319
Global E Online
GLBE
$7.11B
$373K 0.01%
18,447
+7,445
+68% +$171K
SDVY icon
1320
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.8B
$373K 0.01%
15,621
-16,015
-51% -$419K
SON icon
1321
Sonoco
SON
$5.74B
$373K 0.01%
6,544
+194
+3% +$11.5K
SPYX icon
1322
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.88B
$372K 0.01%
12,099
+10,353
+593% +$345K
TPTX
1323
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$372K 0.01%
4,941
+3,774
+323% +$168K
AGM icon
1324
Federal Agricultural Mortgage
AGM
$2.56B
$371K 0.01%
3,801
-3,413
-47% -$351K
EBS icon
1325
Emergent Biosolutions
EBS
$248M
$371K 0.01%
11,948
+10,567
+765% +$361K
51 52
53
54 55

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.